Yinhong Song

Dr. Yinhong Song


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
ZLZihan Liang
Zihan Liang
YWYiyao Wang
Yiyao Wang
YLYixiang Lai
Yixiang Lai
JZJingyi Zhang
Jingyi Zhang
LYLanlan Yin
Lanlan Yin
YSYinhong Song
Yinhong Song
Klebsiella pneumoniae (K. pneumoniae) is a typical gram-negative iatrogenic bacterium that often causes bacteremia, pneumonia and urinary tract infection particularly among those with low immunity. Although antibiotics is the cornerstone of anti-infections, the clinical efficacy of β-lactamase and carbapenems drugs has been weakened due to the emergence of drug-resistant K. pneumoniae. Recent studies have demonstrated that host defense plays a critical role in killing K. pneumoniae. Here, we summarize our current understanding of host immunity mechanisms against K. pneumoniae, including mechanical barrier, innate immune cells, cellular immunity and humoral immunity, providing a theoretical basis and the new strategy for the clinical treatment of K. pneumoniae through improving host immunity.

7 July 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
LBLei Bao
Lei Bao
PZPing Zhu
Ping Zhu
YMYuan Mou
Yuan Mou
YSYinhong Song
Yinhong Song
YQYe Qin
Ye Qin
Lysine-specific demethylase 1 (LSD1) is an enzyme that removes lysine methylation marks from nucleosome histone tails and plays an important role in cancer initiation, progression, metastasis, and recurrence. Recent research shows that LSD1 regulates tumor cells and immune cells through multiple upstream and downstream pathways, enabling tumor cells to adapt to the tumor microenvironment (TME). As a potential anti-tumor treatment strategy, immunotherapy has developed rapidly in the past few years. However, most patients have a low response rate to available immune checkpoint inhibitors (ICIs), including anti-PD-(L)1 therapy and CAR-T cell therapy, due to a broad array of immunosuppressive mechanisms. Notably, inhibition of LSD1 turns “cold tumors” into “hot tumors” and subsequently enhances tumor cell sensitivity to ICIs. This review focuses on recent advances in LSD1 and tumor immunity and discusses a potential therapeutic strategy for combining LSD1 inhibition with immunotherapy.

8 May 2025 in International Immunopharmacology
Verified
Journal Article
Open access
YLYalan Liu
Yalan Liu
CZChong Zhao
Chong Zhao
LCLihong Cui
Lihong Cui
YCYan Chen
Yan Chen
HPHua Peng
Hua Peng
YSYinhong Song
Yinhong Song
Sepsis is a major cause of mortality in neonates, yet understanding of sepsis-associated immune dysregulation in early life remains limited. Sepsis-induced thymus atrophy results in disruption of T cell development, accompanied by the dysfunction of thymic epithelial cells (TECs). Here, we sought to identify molecular mechanisms underlying TECs dysfunction while induced sepsis in neonatal mice and immortalized TECs cell line (iTECs) via lipopolysaccharide (LPS) treatment. We identified that LPS induced a reduction in thymocytes number starting at the double-negative stage of thymocyte development and significantly reduced numbers of naïve T cells and recent thymic emigrants (RTEs). Further we confirmed the alterations of intrathymic cytokines influencing T cell development and functionality through the FOXN1 signaling pathway upon exposure to LPS ex vivo and in vivo. LPS treatment decreased the number of cortical TECs (cTECs) and medullary TECs (mTECs) by enhancing the apoptosis of cTECs and decreasing the proliferation of mTECs. These findings provide valuable insights for further study on the innate and specific immunity in response to neonatal sepsis.

23 April 2025 in Fitoterapia
Verified
Journal Article
Closed access
ZHZhong He
Zhong He
HLHui Long
Hui Long
HMHongyue Ma
Hongyue Ma
WRWanrong Ran
Wanrong Ran
YSYinhong Song
Yinhong Song
ZDZhangshuang Deng
Zhangshuang Deng

1 August 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
LSLanqi Shang
Lanqi Shang
WXWeijia Xiang
Weijia Xiang
MLMengting Lun
Mengting Lun
SQSongyan Qu
Songyan Qu
YYYizhen Yin
Yizhen Yin
YSYinhong Song
Yinhong Song
Listeria monocytogenes (Lm) is a foodborne Gram-positive pathogenic bacterium that primarily causes clinical manifestations such as sepsis, meningitis, and monocytosis. The main susceptible populations include newborns, pregnant women, adults over 40 years old, and immunocompromised individuals. Currently, antibiotic therapy remains the primary clinical treatment, but in recent years the issue of antibiotic resistance has become increasingly prominent. This review summarizes recent advances in host immune mechanisms against Lm infection, focusing on: (1) the defensive roles of host barrier systems (intestinal, blood-brain, and placental barriers); (2) innate immune responses, including pathogen recognition via TLRs/NLRs signaling pathways, macrophage phagocytosis, and NK cell immune surveillance; and (3) adaptive immunity, particularly CD4+/CD8+ T cell-mediated specific immune responses and the long-term protective effects of memory T cells. By systematically elucidating the molecular mechanisms of these immune processes, this review aims to provide novel therapeutic strategies through enhancement of host immune functions for clinical management of Lm infection.

1 June 2026 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
YXYa Xu
Ya Xu
WXWeijia Xiang
Weijia Xiang
WZWanyi Zhu
Wanyi Zhu
LSLanqi Shang
Lanqi Shang
MLMengting Lun
Mengting Lun
YSYinhong Song
Yinhong Song
Hepatocellular carcinoma (HCC) is among the most prevalent malignancies of the digestive system, with a global rising incidence. Hedyotis diffusa Willd and Scutellaria barbata D. Don are classic herb pair in traditional Chinese medicine (TCM) of clearing heat and detoxifying, and is widely applied in the treatment of HCC. Although existing research has confirmed their efficacy against HCC through modulation of apoptosis, proliferation, angiogenesis, and immune responses, it is noteworthy that the combined or newly generated components after the compatibility of the two herbs exhibit even more pronounced therapeutic effects. In order to verify the pharmacological activity of the combination of Hedyotis diffusa Willd and Scutellaria barbata D. Don, it is necessary to try more in vitro and in vivo models. This review synthesizes current evidence on their TCM compatibility principles, pharmacological actions, and related signaling pathways of this herb pair, providing a rigorous theoretical foundation to guide rational clinical application and further translational research on the compatibility mechanism of the Hedyotis diffusa Willd–Scutellaria barbata D. Don herb pair in the treatment of HCC.